- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | NeuroPace (NASDAQ:NPCE) Given New $14.00 Price Target at JPMorgan Chase & Co. | 4 | MarketBeat | ||
| 12.12. | NeuroPace, Inc.: NeuroPace to Host Investor Day on January 28th in New York City | 2 | GlobeNewswire (USA) | ||
| 04.12. | NeuroPace, Inc.: NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting | 2 | GlobeNewswire (USA) | ||
| 03.12. | NeuroPace, Inc.: NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome | 43 | GlobeNewswire (Europe) | MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy... ► Artikel lesen | |
| NEUROPACE Aktie jetzt für 0€ handeln | |||||
| 13.11. | NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 12.11. | NeuroPace Inc - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11. | NeuroPace Inc - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | NeuroPace submits RNS System study data to FDA | 4 | Investing.com | ||
| 04.11. | NeuroPace, Inc.: NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy | 46 | GlobeNewswire (Europe) | The RNS System Post-Approval Study (PAS) is the largest prospective post-approval study in neuromodulation for patients with drug-resistant focal epilepsy The RNS System PAS evaluates safety and... ► Artikel lesen | |
| 28.10. | NeuroPace-Großaktionär KCK Ltd. verkauft Aktien im Wert von 1,22 Millionen US-Dollar | - | Investing.com Deutsch | ||
| 24.10. | NeuroPace Inc verzeichnet Aktienverkauf von 24.853 US-Dollar durch Großaktionär | 1 | Investing.com Deutsch | ||
| 23.10. | Neuropace-Aktie erreicht 52-Wochen-Tief bei 5,66 US-Dollar | 1 | Investing.com Deutsch | ||
| 22.10. | NeuroPace, Inc.: NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 | 1 | GlobeNewswire (USA) | ||
| 18.10. | NeuroPace Inc: KCK Ltd. verkauft Aktien im Wert von 303.366 US-Dollar | 2 | Investing.com Deutsch | ||
| 16.10. | NeuroPace ernennt neue Vizepräsidentin für Personalwesen | 1 | Investing.com Deutsch | ||
| 16.10. | NeuroPace, Inc.: NeuroPace Continues to Strengthen Management Team | 1 | GlobeNewswire (USA) | ||
| 04.09. | NeuroPace adds former Boston Scientific DBS marketing head, former Magnus Medical CEO as VPs | 2 | MassDevice | ||
| 04.09. | NeuroPace names new vice presidents for R&D and marketing | 1 | Investing.com | ||
| 04.09. | NeuroPace, Inc.: NeuroPace Strengthens Management Team with Two Key Appointments | 1 | GlobeNewswire (USA) | ||
| 27.08. | NeuroPace, Inc.: NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,162 | +1,04 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | +3,04 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,075 | +3,71 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 0,960 | -0,52 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| GOODRX | 4,450 | -0,89 % | GoodRx stock rises 5% after new CEO appointment | ||
| JOINT CORP | 10,300 | +0,10 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| TALKSPACE | 2,985 | -0,83 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| MIMEDX | 9,110 | +0,33 % | MiMedx Group, Inc: MIMEDX Files Patent Infringement Lawsuit Against Surgenex | ||
| PROCEPT BIOROBOTICS | 81,25 | +0,58 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,885 | -4,73 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,725 | +2,25 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROGYNY | 14,350 | +1,13 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| BIOMERICA | 0,275 | +3,46 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| PROPHASE LABS | 0,630 | -3,54 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline | ||
| AMWELL | 7,860 | +0,38 % | Amwell CFO Mark Hirschhorn takes on expanded role as COO |
Das Unternehmen NEUROPACE INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,230 (+2,06 %) liegt der Kurs bei 11,370 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROPACE INC finden Sie auf Wallstreet Online.
